Terminalia chebula-based therapeutic composition for the oral treatment of psoriasis

摘要

The subject of the invention is a therapeutic composition for the treatment of psoriasis which can be administered orally, characterised in that it comprises, as active ingredient, an aqueous extract obtained from a mixture of Terminalia chebula, Foeniculum vulgare mill and Linum usitatissinum, the mixture comprising 2 to 40 parts by weight of Foeniculum vulgare mill and 3 to 60 parts by weight of Linum usitatissinum per 100 parts by weight of Terminalia chebula.